Mirror PR to Forgejo / mirror (pull_request) Waiting to run

Details

vida: extract claims from 2026-05-12-fda-glp1-telehealth-warning-letters-screening-gap

- Source: inbox/queue/2026-05-12-fda-glp1-telehealth-warning-letters-screening-gap.md
- Domain: health
- Claims: 3, Entities: 5
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

2026-05-12 08:34:38 +00:00

1.3 KiB

Raw Blame History

type

entity_type

name

domain

status

founded

headquarters

funding

key_people

Telegra

Overview

Telegra is one of four nationwide medical groups providing prescribing infrastructure for GLP-1 telehealth platforms. STAT News investigation (March 2026) identified Telegra as part of a concentrated network supporting at least 30% of telehealth firms that received FDA warning letters for misleading GLP-1 marketing.

Business Model

Provides affiliated clinician services for telehealth platforms. The business model separates marketing (telehealth platform) from prescribing (medical group), creating accountability gaps where neither entity takes full responsibility for the patient journey.

Regulatory Context

FDA warning letters (March 2026) targeted telehealth marketing firms, not the affiliated medical groups directly. However, the concentrated network structure (4 groups supporting 30%+ of warned firms) creates regulatory leverage point.

Timeline

2026-03-12 — Identified by STAT News as one of four medical groups affiliated with 30%+ of FDA-warned GLP-1 telehealth firms

Sources

STAT News investigation, March 12, 2026

1.3 KiB Raw Blame History